335 related articles for article (PubMed ID: 1444296)
1. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria.
Brochu A; Brochu N; Nicas TI; Parr TR; Minnick AA; Dolence EK; McKee JA; Miller MJ; Lavoie MC; Malouin F
Antimicrob Agents Chemother; 1992 Oct; 36(10):2166-75. PubMed ID: 1444296
[TBL] [Abstract][Full Text] [Related]
2. Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates.
Minnick AA; McKee JA; Dolence EK; Miller MJ
Antimicrob Agents Chemother; 1992 Apr; 36(4):840-50. PubMed ID: 1503447
[TBL] [Abstract][Full Text] [Related]
3. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria.
Diarra MS; Lavoie MC; Jacques M; Darwish I; Dolence EK; Dolence JA; Ghosh A; Ghosh M; Miller MJ; Malouin F
Antimicrob Agents Chemother; 1996 Nov; 40(11):2610-7. PubMed ID: 8913474
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxy-L-ornithine-derived siderophore-beta-lactam conjugates: iron-transport-mediated drug delivery.
Dolence EK; Minnick AA; Lin CE; Miller MJ; Payne SM
J Med Chem; 1991 Mar; 34(3):968-78. PubMed ID: 1825850
[TBL] [Abstract][Full Text] [Related]
5. Selective growth promotion and growth inhibition of gram-negative and gram-positive bacteria by synthetic siderophore-beta-lactam conjugates.
Möllmann U; Ghosh A; Dolence EK; Dolence JA; Ghosh M; Miller MJ; Reissbrodt R
Biometals; 1998 Jan; 11(1):1-12. PubMed ID: 9450313
[TBL] [Abstract][Full Text] [Related]
6. Growth of Actinobacillus pleuropneumoniae is promoted by exogenous hydroxamate and catechol siderophores.
Diarra MS; Dolence JA; Dolence EK; Darwish I; Miller MJ; Malouin F; Jacques M
Appl Environ Microbiol; 1996 Mar; 62(3):853-9. PubMed ID: 8975614
[TBL] [Abstract][Full Text] [Related]
7. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
Gunkel AG; Hechler U; Martin HH
J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada.
Clairoux N; Picard M; Brochu A; Rousseau N; Gourde P; Beauchamp D; Parr TR; Bergeron MG; Malouin F
Antimicrob Agents Chemother; 1992 Jul; 36(7):1504-13. PubMed ID: 1510447
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals.
Rousseau N; Dargis M; Gourde P; Beauchamp D; Malouin F
Antimicrob Agents Chemother; 1992 Oct; 36(10):2147-55. PubMed ID: 1444294
[TBL] [Abstract][Full Text] [Related]
10. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
Chambers HF; Moreau D; Yajko D; Miick C; Wagner C; Hackbarth C; Kocagöz S; Rosenberg E; Hadley WK; Nikaido H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2620-4. PubMed ID: 8592990
[TBL] [Abstract][Full Text] [Related]
11. Interaction of beta-lactam antibiotics with the penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae.
Ikeda F; Yokota Y; Ikemoto A; Teratani N; Shimomura K; Kanno H
Chemotherapy; 1995; 41(3):159-64. PubMed ID: 7656660
[TBL] [Abstract][Full Text] [Related]
12. Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins.
Satta G; Cornaglia G; Mazzariol A; Golini G; Valisena S; Fontana R
Antimicrob Agents Chemother; 1995 Apr; 39(4):812-8. PubMed ID: 7785976
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Yersinia pestis penicillin-binding proteins with beta-lactam antibiotics.
Ferreira RC; Park JT; Camelo D; De Almeida DF; Ferreira LC
Antimicrob Agents Chemother; 1995 Aug; 39(8):1853-5. PubMed ID: 7486931
[TBL] [Abstract][Full Text] [Related]
14. The design, synthesis and study of siderophore-antibiotic conjugates. Siderophore mediated drug transport.
Miller MJ; McKee JA; Minnick AA; Dolence EK
Biol Met; 1991; 4(1):62-9. PubMed ID: 1830210
[TBL] [Abstract][Full Text] [Related]
15. Penicillin-binding proteins in Streptococcus faecalis and S. faecium.
Chen HY; Williams JD
J Med Microbiol; 1987 Mar; 23(2):141-7. PubMed ID: 3104591
[TBL] [Abstract][Full Text] [Related]
16. Shifting of the penicillin binding proteins that are the target for inhibition by beta-lactams as a likely mechanism of resistance to antibiotics during therapy.
Satta G; Canepari P; Maurici R; Pompei R; Marcialis MA
Chemioterapia; 1985 Feb; 4(1):113-5. PubMed ID: 3986940
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
[TBL] [Abstract][Full Text] [Related]
18. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.
Nagai K; Davies TA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2002 May; 46(5):1273-80. PubMed ID: 11959556
[TBL] [Abstract][Full Text] [Related]
19. Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and binding.
Koupal LR; Pelak BA; Cassidy PJ; Gadebusch HH
J Antibiot (Tokyo); 1983 Jan; 36(1):54-63. PubMed ID: 6381447
[TBL] [Abstract][Full Text] [Related]
20. Role of permeability barriers in resistance to beta-lactam antibiotics.
Nikaido H
Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
